Versant Venture Capital IV, L.P., Director at CRISPR Therapeutics AG (CRSP), sold 13,679 shares at $57.09 ($781K) on 2026-09-17, disclosed to the SEC on 2026-09-21.
Open-market sale of $781k CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |